OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 2 filers reported holding OYSTER PT PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $275,000 | +29.7% | 48,934 | 0.0% | 0.00% | – |
| Q2 2022 | $212,000 | -91.0% | 48,934 | -75.7% | 0.00% | – |
| Q1 2022 | $2,346,000 | -21.3% | 201,569 | +23.4% | 0.00% | – |
| Q4 2021 | $2,982,000 | +54.7% | 163,328 | +0.4% | 0.00% | – |
| Q3 2021 | $1,928,000 | -19.9% | 162,706 | +16.1% | 0.00% | – |
| Q2 2021 | $2,408,000 | +21.9% | 140,107 | +29.7% | 0.00% | – |
| Q1 2021 | $1,975,000 | -5.4% | 108,033 | -2.6% | 0.00% | – |
| Q4 2020 | $2,088,000 | -3.2% | 110,956 | +8.6% | 0.00% | – |
| Q3 2020 | $2,156,000 | -22.2% | 102,132 | +6.4% | 0.00% | – |
| Q2 2020 | $2,772,000 | -16.2% | 95,971 | +1.6% | 0.00% | – |
| Q1 2020 | $3,306,000 | +218.8% | 94,453 | +122.6% | 0.00% | – |
| Q4 2019 | $1,037,000 | – | 42,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $15,559,000 | 8.54% |
| NEA Management Company, LLC | 5,925,287 | $33,300,000 | 1.66% |
| KPCB XIV Associates, LLC | 367,987 | $2,068,000 | 1.61% |
| Paradigm Biocapital Advisors LP | 1,648,316 | $9,264,000 | 1.24% |
| Telemark Asset Management, LLC | 777,026 | $4,367,000 | 0.69% |
| COWEN AND COMPANY, LLC | 509,794 | $2,865,000 | 0.27% |
| RTW INVESTMENTS, LP | 2,044,312 | $11,489,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $5,843,000 | 0.12% |
| Wildcat Capital Management, LLC | 36,847 | $207,000 | 0.08% |
| ACT CAPITAL MANAGEMENT, LLC | 8,500 | $48,000 | 0.07% |